These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 8553567)
1. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567 [TBL] [Abstract][Full Text] [Related]
2. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Khanna R; Burrows SR; Nicholls J; Poulsen LM Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727 [TBL] [Abstract][Full Text] [Related]
4. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222 [TBL] [Abstract][Full Text] [Related]
5. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. Levitsky V; Zhang QJ; Levitskaya J; Masucci MG J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295 [TBL] [Abstract][Full Text] [Related]
6. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. Kienzle N; Sculley TB; Poulsen L; Buck M; Cross S; Raab-Traub N; Khanna R J Virol; 1998 Aug; 72(8):6614-20. PubMed ID: 9658107 [TBL] [Abstract][Full Text] [Related]
7. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044 [TBL] [Abstract][Full Text] [Related]
8. Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing. Khanna R; Burrows SR; Steigerwald-Mullen PM; Moss DJ; Kurilla MG; Cooper L Int Immunol; 1997 Oct; 9(10):1537-43. PubMed ID: 9352359 [TBL] [Abstract][Full Text] [Related]
9. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791 [TBL] [Abstract][Full Text] [Related]
10. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. Khanna R; Burrows SR; Moss DJ; Silins SL J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046 [TBL] [Abstract][Full Text] [Related]
11. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. Lee SP; Thomas WA; Murray RJ; Khanim F; Kaur S; Young LS; Rowe M; Kurilla M; Rickinson AB J Virol; 1993 Dec; 67(12):7428-35. PubMed ID: 7693972 [TBL] [Abstract][Full Text] [Related]
12. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies. Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531 [TBL] [Abstract][Full Text] [Related]
13. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. Gavioli R; Kurilla MG; de Campos-Lima PO; Wallace LE; Dolcetti R; Murray RJ; Rickinson AB; Masucci MG J Virol; 1993 Mar; 67(3):1572-8. PubMed ID: 7679748 [TBL] [Abstract][Full Text] [Related]
14. Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells. Ito Y; Demachi-Okamura A; Ohta R; Akatsuka Y; Nishida K; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K J Gen Virol; 2007 Mar; 88(Pt 3):770-780. PubMed ID: 17325349 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828 [TBL] [Abstract][Full Text] [Related]
17. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456 [TBL] [Abstract][Full Text] [Related]
18. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro. Morgan SM; Wilkinson GW; Floettmann E; Blake N; Rickinson AB J Virol; 1996 Apr; 70(4):2394-402. PubMed ID: 8642667 [TBL] [Abstract][Full Text] [Related]
19. Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. Tellam J; Connolly G; Green KJ; Miles JJ; Moss DJ; Burrows SR; Khanna R J Exp Med; 2004 May; 199(10):1421-31. PubMed ID: 15148340 [TBL] [Abstract][Full Text] [Related]
20. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines. Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]